Avanos Medical Inc (FRA:8HH)
€ 21.4 (0%) Market Cap: 1.03 Bil Enterprise Value: 1.09 Bil PE Ratio: 0 PB Ratio: 1.49 GF Score: 62/100

Avanos Medical Inc at JPMorgan Healthcare Conference Transcript

Jan 13, 2026 / 10:15PM GMT
Release Date Price: €10.1 (-2.88%)
JanLuke Iftime
JPMorgan Chase & Co - Analyst

Good afternoon, everyone, and thank you for joining us this week at the JPMorgan Healthcare Conference. Great to have you all this afternoon join us. My name is JanLuke Iftime, and I'm an associate on the JPMorgan Healthcare team.

Today, it is my pleasure to introduce Avanos Medical. Joining us for today's presentation is Dave Pacitti, CEO of Avanos; and Scott Galovan, CFO of Avanos. Following the presentation, we'll have brief time for a Q&A session.

With that, I'll turn it over to Dave.

David Pacitti
Avanos Medical Inc - Chief Executive Officer

Thanks, everyone. Thanks for joining us. My name is Dave Pacitti. I'm the CEO of Avanos.

At Avanos, our purpose is quite simple, getting patients back to things that matter in their lives. And today, I'll walk you through how that purpose translates into a durable long-term strategy, a focused strategy, durable growth, and most importantly, long-term value creation for the company.

And just the normal disclosures before we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot